Charcot-Marie-Tooth disease (CMT) is the most common inherited disorder of the peripheral nervous system with an estimated frequency of 1/2500.' CMT is characterised by distal muscle weakness and amyotrophy, descreased or absent tendon reflexes, and highly arched feet.2 CMT patient (fig 1A) . Direct sequencing showed that the patient was heterozygous for a point mutation (499delG) (fig 1C) that caused a frameshift, introducing a premature stop codon (TAG) at nucleotide 643. The resulting transcript encoded a Cx32 protein of 194 amino acids, truncated in the fourth transmembrane region, and lacking the intracellular COOH terminal domain, which seems to be of importance, since many point mutations and deletions in this sequence are associated with CMTX.91' This previously unreported mutation is therefore very probably the cause of the CMTX phenotype in this patient. The mutation was not detected in the patient's parents or sibs by single strand conformation polymorphism (SSCP) or by PCR/restriction techniques ( fig 1A, B) . Automated sequence analysis of the 287 bp fragment confirmed its absence in the parent's DNA ( fig 1C) . False paternity was excluded by analysis of allele segregation with nine highly polymorphic markers located on chromosomes 13, 17, and X (data not shown). The deletion in the patient's Cx32 gene was therefore a de novo mutation.
This case is interesting for two reasons.
(1) It is, to our knowledge, the first reported de novo mutation of the Cx32 gene in X linked Charcot-Marie-Tooth disease. Unfortunately, it could not be determined, for this female patient, whether the chromosome on which the mutation occurred was of paternal or maternal origin, since the patient had no offspring and the haplotype segregating with the deletion could not be reconstructed. (2) 
